(Q37006972)

English

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol

scientific article published on 07 June 2016

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

17 August 2017

β-Blockers for the prevention of acute exacerbations of chronic obstructive pulmonary disease (βLOCK COPD): a randomised controlled study protocol (English)

1 reference

Europe PubMed Central

17 August 2017

chronic obstructive pulmonary disease

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

author name string

Surya P Bhatt

1

1 reference

Europe PubMed Central

17 August 2017

John E Connett

2

1 reference

Europe PubMed Central

17 August 2017

Helen Voelker

3

1 reference

Europe PubMed Central

17 August 2017

Sarah M Lindberg

4

1 reference

Europe PubMed Central

17 August 2017

Elizabeth Westfall

5

1 reference

Europe PubMed Central

17 August 2017

J Michael Wells

6

1 reference

Europe PubMed Central

17 August 2017

Stephen C Lazarus

7

1 reference

Europe PubMed Central

17 August 2017

Gerard J Criner

8

1 reference

Europe PubMed Central

17 August 2017

Mark T Dransfield

9

1 reference

Europe PubMed Central

17 August 2017

publication date

7 June 2016

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

6

1 reference

Europe PubMed Central

17 August 2017

e012292

1 reference

Europe PubMed Central

17 August 2017

6

1 reference

Europe PubMed Central

17 August 2017

β-Blockers are associated with a reduction in COPD exacerbations

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Resting heart rate is a risk factor for mortality in chronic obstructive pulmonary disease, but not for exacerbations or pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

β₂-Adrenergic agonists augment air pollution-induced IL-6 release and thrombosis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Simvastatin for the prevention of exacerbations in moderate-to-severe COPD

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Cardiovascular risk, myocardial injury, and exacerbations of chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

2013 ACCF/AHA Guideline for the Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Chronic obstructive pulmonary disease and cardiovascular disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Azithromycin for prevention of exacerbations of COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Diagnosis and Management of Stable Chronic Obstructive Pulmonary Disease: A Clinical Practice Guideline Update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Effect of beta blockers in treatment of chronic obstructive pulmonary disease: a retrospective cohort study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Percent emphysema, airflow obstruction, and impaired left ventricular filling

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Pulmonary effects of nebivolol

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Inhaled drugs to reduce exacerbations in patients with chronic obstructive pulmonary disease: a network meta-analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Chronic exposure to beta-blockers attenuates inflammation and mucin content in a murine asthma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

The epidemiology and economics of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Counting, analysing and reporting exacerbations of COPD in randomised controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

A coronary heart disease risk score based on patient-reported information

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Cardioselective beta-blockers for chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Prevention of exacerbations of chronic obstructive pulmonary disease with tiotropium, a once-daily inhaled anticholinergic bronchodilator: a randomized trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity and mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Cardioprotection: the role of beta-blocker therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Antibiotic therapy in exacerbations of chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

29 September 2017

Changes in beta 2-adrenoceptor and other signaling proteins produced by chronic administration of 'beta-blockers' in a murine asthma model

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

27 June 2018

International conference on harmonisation of technical requirements for registration of pharmaceuticals for human use (ICH)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

27 June 2018

Effects of muliple doses of metoprolol and propranolol on ventilatory function in patients with chronic obstructive lung disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

27 June 2018

Cardiac Sympathetic Dominance and Systemic Inflammation in COPD.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Beta-blocker therapy in patients with left ventricular systolic dysfunction and chronic obstructive lung disease in an ambulatory care setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Effects of cardiovascular drugs on mortality in severe chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

2012 ACCF/AHA/ACP/AATS/PCNA/SCAI/STS Guideline for the Diagnosis and Management of Patients With Stable Ischemic Heart

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Changes in COPD demographics and costs over 20 years.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Arrhythmias as trigger for acute exacerbations of chronic obstructive pulmonary disease.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Beta-blockers may reduce mortality and risk of exacerbations in patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Cardioselective beta-blockers for chronic obstructive pulmonary disease: a meta-analysis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Metoprolol, a Β-1 selective blocker, can be used safely in coronary artery disease patients with chronic obstructive pulmonary disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4908863

4 September 2018

Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Lung function with carvedilol and bisoprolol in chronic heart failure: Is β selectivity relevant?

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparative effects of celiprolol, propranolol, oxprenolol, and atenolol on respiratory function in hypertensive patients with chronic obstructive lung disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Management of stable chronic obstructive pulmonary disease in primary and secondary care: summary of updated NICE guidance

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sub-clinical left ventricular diastolic dysfunction in early stage of chronic obstructive pulmonary disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

β-Blocker use and incidence of chronic obstructive pulmonary disease exacerbations

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

COPD9USA June 2015.

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of beta-blockade on mortality among high-risk and low-risk patients after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/27267111

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/BMJOPEN-2016-012292

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

1 reference

Europe PubMed Central

17 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37006972&oldid=1634996201"